Opinion

Video

Role of Lp(a) in ASCVD Risk

Author(s):

Seth Baum, MD,Erin D. Michos, MD, MHS

Key Takeaways

  • Pediatric lipid screening is vital for early dyslipidemia detection, reducing future cardiovascular disease risk.
  • Guidelines suggest universal screening at ages 9-11 and 17-21, with selective screening for at-risk children.
SHOW MORE

Panelists discuss how Lp(a), a distinct lipoprotein particle from LDL, independently contributes to ASCVD risk through its unique structural properties and atherogenic potential.

Video content above is prompted by the following:

  • What is the role played by lipoprotein(a) (Lp[a]) in developing ASCVD?
    • How does Lp(a) differ from LDL?
Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
4 experts are featured in this series.
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Related Content
Atumelnant Reduces Key CAH Biomarkers, Hits Primary Phase 2 Endpoint | Image Credit: Crinetics Pharmaceuticals
January 10th 2025

Atumelnant Reduces Key CAH Biomarkers, Hits Primary Phase 2 Endpoint

Connor Iapoce
Diabetes Dialogue: Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas | Image Credit: HCPLive
January 6th 2025

Diabetes Dialogue: Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Bayer Submits Finerenone Application to FDA for Treatment of Heart Failure | Image Credit: US Food and Drug Administration
January 10th 2025

Bayer Submits Finerenone Application to FDA for Treatment of Heart Failure

Connor Iapoce
Skin of Color Savvy: Itch in Skin of Color, with Andrew Alexis, MD, MPH, and Shawn Kwatra, MD
January 6th 2025

Skin of Color Savvy: Itch in Skin of Color, with Andrew Alexis, MD, MPH, and Shawn Kwatra, MD

Andrew F Alexis, MD, MPH Shawn Kwatra, MD
4D-150 Reduces Injection Burden in DME, Paving Way for FDA-Backed Phase 3| Image Credit: LinkedIn
January 10th 2025

4D-150 Reduces Injection Burden in DME, Paving Way for FDA-Backed Phase 3

Connor Iapoce
Study Highlights Findings on Chronic Hand Eczema from Skin Tape Stripping
January 10th 2025

Study Highlights Findings on Chronic Hand Eczema from Skin Tape Stripping

Tim Smith
© 2025 MJH Life Sciences

All rights reserved.